10-Year Update on Study Results Submitted to ClinicalTrials.gov | NEJM
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events—a meta-analysis - Annals of Oncology
How to Understand and Get the Most Out of ClinicalTrials.gov - CLL Society
Final Rule Confirms, Posting of Study Results on ClinicalTrials.gov Will be Required for Unapproved Products - IMPACT Pharmaceutical Services, Inc.
Clinical Trial Registration — Looking Back and Moving Ahead | NEJM
10-Year Update on Study Results Submitted to ClinicalTrials.gov | NEJM
Lay Summaries of Clinical Study Results: An Overview | SpringerLink
10-Year Update on Study Results Submitted to ClinicalTrials.gov | NEJM
Most Covid clinical trials are slow to make results public – new study
Patient-Centeredness in the Design of Clinical Trials - ScienceDirect
Laser Focal Therapy - 10 Year Phase II Clinical Trial Results | HALO Diagnostics
ASH 2020: Results From the Phase 1/2 BRUIN Trial
How Frequently Do the Results from Completed US Clinical Trials Enter the Public Domain? - A Statistical Analysis of the ClinicalTrials.gov Database | PLOS ONE
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis | BMJ Open
The effects of releasing early results from ongoing clinical trials | Nature Communications
A young researcher's guide to a clinical trial and its registration | Editage Insights